Modulation of axon degeneration

Details for Australian Patent Application No. 2009308293 (hide)

Owner Genentech, Inc.

Inventors Watts, Ryan; Chen, Mark; Lewcock, Joseph Wesley; Pozniak, Christine; Sengupta-Ghosh, Arundhati

Agent Griffith Hack

Pub. Number AU-A-2009308293

PCT Pub. Number WO2010/048446

Priority 61/197,051 22.10.08 US

Filing date 22 October 2009

Wipo publication date 29 April 2010

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 May 2011 PCT application entered the National Phase

  PCT publication WO2010/048446 Priority application(s): WO2010/048446

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009308302-Compositions and methods for treating matrix metalloproteinase 9 (MMP9)-mediated conditions

2009308286-Data storage devices